BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 8816390)

  • 1. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
    Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
    J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC class II-independent, Vbeta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinoma.
    Newton DW; Dohlsten M; Lando PA; Kalland T; Olsson C; Kotb M
    Int J Mol Med; 1998 Jan; 1(1):157-62. PubMed ID: 9852214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity.
    Lando PA; Dohlsten M; Hedlund G; Brodin T; Sansom D; Kalland T
    Immunology; 1993 Oct; 80(2):236-41. PubMed ID: 7505257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Linsley PS
    J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
    Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
    Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.
    Damle NK; Leytze G; Klussman K; Ledbetter JA
    Eur J Immunol; 1993 Jul; 23(7):1513-22. PubMed ID: 8100773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
    Lamphear JG; Stevens KR; Rich RR
    J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity.
    Newton DW; Dohlsten M; Olsson C; Segrén S; Lundin KE; Lando PA; Kalland T; Kotb M
    J Immunol; 1996 Nov; 157(9):3988-94. PubMed ID: 8892632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
    Dennig D; Yan Y; Ferguson K; O'Reilly RJ
    Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation.
    Tiedemann RE; Fraser JD
    J Immunol; 1996 Nov; 157(9):3958-66. PubMed ID: 8892628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes.
    Frandji P; Tkaczyk C; Oskeritzian C; David B; Desaymard C; Mécheri S
    Eur J Immunol; 1996 Oct; 26(10):2517-28. PubMed ID: 8898968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
    Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superantigen and HLA-DR ligation induce phospholipase-C gamma 1 activation in class II+ T cells.
    Kanner SB; Odum N; Grosmaire L; Masewicz S; Svejgaard A; Ledbetter JA
    J Immunol; 1992 Dec; 149(11):3482-8. PubMed ID: 1385526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulation of human CD4+ T lymphocytes with B7 and lymphocyte function-associated antigen-3 results in distinct cell activation profiles.
    Parra E; Wingren AG; Hedlund G; Björklund M; Sjögren HO; Kalland T; Sansom D; Dohlsten M
    J Immunol; 1994 Sep; 153(6):2479-87. PubMed ID: 7521363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcal enterotoxin-mediated human T-T cell interactions.
    Koning F; Rust C
    J Immunol; 1992 Jul; 149(1):317-22. PubMed ID: 1535087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique cytokine production profile of anergic human T cells in SCID-hu mice after staphylococcal enterotoxin B administration.
    Schols D; Jones D; Roncarolo MG
    J Immunol; 1995 Apr; 154(7):3204-12. PubMed ID: 7534791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcal enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with the MHC class II receptors.
    Al-Daccak R; Mehindate K; Damdoumi F; Etongué-Mayer P; Nilsson H; Antonsson P; Sundström M; Dohlsten M; Sékaly RP; Mourad W
    J Immunol; 1998 Jan; 160(1):225-32. PubMed ID: 9551975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands.
    Ding L; Shevach EM
    J Immunol; 1998 Dec; 161(12):6614-21. PubMed ID: 9862689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of the specificity of superantigen to T cell receptor V beta elements in the absence of MHC class II molecules.
    Kotb M; Watanabe-Ohnishi R; Aelion J; Tanaka T; Geller AM; Ohnishi H
    Cell Immunol; 1993 Dec; 152(2):348-57. PubMed ID: 8258143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation of superantigen by human T cell clones: a model of T-T cell interaction.
    Nisini R; Matricardi PM; Fattorossi A; Biselli R; D'Amelio R
    Eur J Immunol; 1992 Aug; 22(8):2033-9. PubMed ID: 1353448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.